학술논문

Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model
Document Type
Article
Source
In: PLoS Pathogens. (PLoS Pathogens, August 2021, 17(8))
Subject
Language
English
ISSN
15537374
15537366